Navigation Links
NYU Langone Medical Center awarded $4.5 million for breast cancer research
Date:4/20/2011

NYU Langone Medical Center announced today the U.S. Department of Defense (DOD) Breast Cancer Research Program (BCRP) of the Office of the Congressionally Directed Medical Research Programs has awarded Silvia Formenti, MD, the Sandra and Edward Meyer Professor and Chair of the Department of Radiation Oncology a $4.5 million Multi-Team Award to conduct novel breast cancer research.

"This Multi-Team Award offers tremendous promise for new therapeutic options for patients with breast cancer and highlights the successes that may become possible through unique synergies of the outstanding team of scientists Dr. Formenti has brought together for this work," said Vivian S. Lee, MD, PhD, MBA, chief scientific officer and vice dean for Science at NYU Langone Medical Center. "The work of Dr. Formenti and her colleagues has already improved patient outcomes and with the recognition and support of the DOD, we anticipate important, high impact research breakthroughs are on the horizon."

As principal investigator, Dr. Formenti will lead a team of researchers to explore the combined effect of radiation therapy and immunotherapy in breast cancer. The study is designed to facilitate rapid translation of discovery from the laboratory to the clinic. The Multi-Team Award research team will include laboratory and clinical scientist teams with a long-standing collaboration from the NYU Cancer Institute and UCLA including Dr. Formenti, Sandra Demaria, MD, associate professor, Department of Pathology and Mary Helen Barcellos-Hoff, PhD, professor, Departments of Radiation Oncology and Cell Biology and UCLA's William McBride, MD, professor of Radiation Oncology.

Previous research by this team has demonstrated in pre-clinical models, the efficiency of combining immunotherapy, radiotherapy and the promise of introducing a TGFβ inhibitor to attack breast cancer tumors. The award will enable researchers to build upon their pre-clinical findings and translate the results to a clinical trial.

Researchers will test in clinical trial the efficiency of a novel antibody to neutralize TGFβ, a protein that controls cancer cell proliferation. The TGFβ inhibitor will target the breast cancer tumor's microenvironment to enhance sensitivity to radiation while stimulating an antitumor response in a patient's immune system. The goal of the study is to test whether by irradiating a metastatic site in combination with an antibody that blocks TGFβ it is possible to induce an effective anti-tumor immune response outside the radiation field in metastatic breast cancer patients. This novel concept is based on the hypothesis that radiation-induced treatment of the tumor site can vaccinate the patient against her own cancer, and enable immune rejection of tumor sites outside the radiation field.

"Our best ally in fighting cancer is our immune system," said Dr. Formenti, who leads the Breast Cancer Research Program at the NYU Cancer Institute. "We hope that the combination treatment of radiation therapy and immunotherapy by TGFβ inhibition will significantly extend survival and improve the quality of life of patients with metastatic breast cancer."

An important component of the Multi-Team Award research team's planning and implementation process will be its collaboration with breast cancer advocates and survivors from SHARE, a non-profit organization whose mission is to create a supportive community of women affected by breast or ovarian cancer and provide medical information.


'/>"/>

Contact: Lauren Woods
lauren.woods@nyumc.org
212-404-3753
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Related medicine news :

1. NYU Langone offers vascular-targeted photodynamic therapy for localized prostate cancer
2. NYU Langone scientists find key pathway implicated in progression of childhood cancer
3. NYU Langone Medical Center receives NIH Directors Transformative Research Projects award
4. NYU Langone Department of Orthopaedic Surgery chosen to participate in joint replacement registry
5. NYU Langone offers new imaging technique to advance robotic surgery for patients
6. NYU Langone Medical Center cardiologists present at ACC 60th Annual Scientific Session
7. TheReliefPlace.com Launches Online Store “The Relief Shop” - What Does this Medical Supply Store Carry and How Can They Help You?
8. Medical Transcription Services and EHR Provider MxSecure Launches New Enhanced Website with Goal of Improved Physician Productivity
9. Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program
10. FDA Seeks Reduction in Radiation From Medical Scans
11. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , ... March 24, 2017 , ... ... to Walk with God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward ... Learning How to Walk with God #TruthwithGrace” is the creation of published author ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion ... real people of God in congregations across the United States. “The Communion ... ordained in 1964 who has served congregations in seven states throughout his long ...
(Date:3/23/2017)... ... March 23, 2017 , ... A recent report from the ... teacher preparation programs. The NCTQ report suggests, based on a review of GPA and ... improve teacher quality in the U.S. It argues that this higher bar should be ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... Texas ... located at 960 Gruene Road in Building 2. The clinic is the group’s second ... Bennett, PT, says opening the company’s second New Braunfels location brings things full circle ...
(Date:3/23/2017)... ... March 23, 2017 , ... The MBI “Hall of Fame” recognizes the contributions of those ... a significant impact on the careers of all others involved. , On Monday, ... into the MBI’s Hall of Fame. The induction took place during the World of ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... -- GenomeDx Biosciences today announced that six abstracts featuring Decipher ... Classifier tests will be presented at the 32 nd ... March 24 to 28, 2017 in London, ... Europe,s largest urological event showcasing the ... The abstract titled "Muscle invasive bladder cancer: ...
(Date:3/24/2017)... , March 23, 2017  Provectus Biopharmaceuticals, Inc. ... "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, ... Financing Commitment Term Sheet (the "Definitive Financing") it ... of the Company,s stockholders, who are referred to ... a Form 8-K filed with the Securities and ...
(Date:3/23/2017)... March 23, 2017 Mosaic Life Care, based in St. Joseph, ... process across its network of 58 clinics, located in 22 cities, and its flagship ... innovative ways to improve the delivery of health care to its patients, including the ... ... Mosaic Life Care St. Joseph Medical Center ...
Breaking Medicine Technology: